Enhancing mHealth Technology to Activate Chronic Care Patients
Enhancing mHealth Technology in the PCMH Environment to Activate Chronic Care Patients
調査の概要
詳細な説明
Multi-site phased study, conducted within the Military Health System that includes a user-centered design phase and a patient centered medical home (PCMH)-based feasibility trial.
In Phase I the investigators will assess both patient and clinician preferences and usability regarding the enhancement of the enabling technology capabilities for Type 2 diabetes chronic self-care management. The data from the experience will be coded and analyzed by the research team and the technology will be adapted accordingly before Phase II.
Phase II research is a single-blinded 12-month feasibility study that seeks to include the enabling technology to support diabetes self-care management with tailored behavioral messaging aimed at reinforcing and encouraging self-care behavior based on patients' readiness. We have included safety thresholds that alert patients and clinical team under certain conditions.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Nevada
-
Nellis Air Force Base、Nevada、アメリカ、89191
- Mike O'Callaghan Federal Medical Center
-
-
Washington
-
Tacoma、Washington、アメリカ、98431
- Madigan Army Medicall Center
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Men and women age 18 years or older,
- Ability to understand and read English,
- Be empanelled to one of the target PCMH sites, and
- Diagnosed with type 2 diabetes.
Exclusion Criteria:
- pregnant women,
- non-English speaking patients,
- receiving hospice care,
- active cancer and treatment with chemotherapy or radiation therapy,
- taking Coumadin,
- recipient of gastric bypass or similar procedure,
- diagnosis of uncontrolled hypothyroidism,
- known Cushing's syndrome,
- being treated with oral steroids,
- known liver disease,
- current diagnosis of cognitive impairments which would interfere with use of technology,
- congestive heart failure New York Heart Association class 3 or 4,
- inability to use a mobile device due to cognitive or physical impairments, and
- PAM® score = 4 during initial screening.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:Intervention
Use of (4) bluetooth-enabled biomedical devices (i.e.
scale, blood pressure cuff, activity monitor, glucose monitor), for use in self care activities, integrated with the mobile health care environment (MHCE) system.
The MHCE system will provide tailored behavioral messages triggered by clinical values and survey responses.
|
An integrated mobile health system modified to support type 2 diabetes self-care activities.
Primary intervention includes visualization and trending of device outcomes AND tailored behavioral messages based on Patient Activation Measure scores.
他の名前:
|
介入なし:Control
Use of (4) bluetooth-enabled biomedical devices (i.e.
scale, blood pressure cuff, activity monitor, glucose monitor), for use in self care activities, NOT integrated with the mobile health care environment (MHCE) system.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Patient Activation Measure (PAM)
時間枠:Every 3 months during the 12-month trial
|
PAM is a validated survey measure of patient activation
|
Every 3 months during the 12-month trial
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Glycosylated hemoglobin (HbA1C)
時間枠:Every 4 months during 12-month trial
|
HbA1c results documented on three occasions
|
Every 4 months during 12-month trial
|
Low-density Lipoprotein (LDL)
時間枠:Every 4 months during 12-month trial
|
LDL results documented on three occasions
|
Every 4 months during 12-month trial
|
High-density Lipoprotein (HDL)
時間枠:Every 4 months during 12-month trial
|
HDL results documented on three occasions
|
Every 4 months during 12-month trial
|
Abdominal circumference
時間枠:Every 4 months during 12-month trial
|
Abdominal measures taken on three occasions
|
Every 4 months during 12-month trial
|
Blood pressure
時間枠:Every 4 months plus patient self-measurement during 12 -month trial
|
Collected in clinic and daily by the patient
|
Every 4 months plus patient self-measurement during 12 -month trial
|
Summary of Diabetes Self-Care Activities (SDSCA)
時間枠:Every 2 weeks during 12-month trial
|
Validated survey measure of diabetes self-care activities
|
Every 2 weeks during 12-month trial
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Ronald W. Gimbel、Clemson University
出版物と役立つリンク
一般刊行物
- Gimbel RW, Rennert LM, Crawford P, Little JR, Truong K, Williams JE, Griffin SF, Shi L, Chen L, Zhang L, Moss JB, Marshall RC, Edwards KW, Crawford KJ, Hing M, Schmeltz A, Lumsden B, Ashby M, Haas E, Palazzo K. Enhancing Patient Activation and Self-Management Activities in Patients With Type 2 Diabetes Using the US Department of Defense Mobile Health Care Environment: Feasibility Study. J Med Internet Res. 2020 May 26;22(5):e17968. doi: 10.2196/17968.
- Gimbel R, Shi L, Williams JE, Dye CJ, Chen L, Crawford P, Shry EA, Griffin SF, Jones KO, Sherrill WW, Truong K, Little JR, Edwards KW, Hing M, Moss JB. Enhancing mHealth Technology in the Patient-Centered Medical Home Environment to Activate Patients With Type 2 Diabetes: A Multisite Feasibility Study Protocol. JMIR Res Protoc. 2017 Mar 6;6(3):e38. doi: 10.2196/resprot.6993.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
2型糖尿病の臨床試験
Mobile Health Care Environment (MHCE)の臨床試験
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes...完了
-
Medical University of Vienna完了
-
University of BirminghamNational Institute for Health Research, United Kingdomわからない